Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Biotechnology

Education

Shoreline Biosciences

Kleanthis G. Xanthopoulos

Krishna Patel

Mauro P. Avanzi

Paschalis Sideras

Charles Calderaro III

Robert Hollingsworth

Scott Forrest

Steven Neben

Vanessa Jacoby

The Leadership Team at Shoreline Biosciences drives the strategic vision and operational direction of the company, leveraging their extensive expertise in cell therapy and biotechnology. Comprising key executives such as the CEO, CFO, and Chief Scientific Officer, the team collaborates to advance innovative iPSC differentiation methods, oversee project management, and forge strategic partnerships, all aimed at enhancing the effectiveness of engineered NK cells in combating cancer.

Leadership Team

Scientific Research

Advisory Team

Leadership Team

About

Team members

Other teams at Shoreline Biosciences

Scientific Research

Advisory Team